Background Multiple observational studies have associated metformin prescription with
reduced progression of abdominal aortic aneurysm (AAA). The Metformin Aneurysm Trial …

Objective A meta-analysis of the association between metformin prescription and abdominal
aortic aneurysm (AAA) growth and events (rupture or surgical repair) was performed …

Objectives Currently there is no drug therapy for abdominal aortic aneurysm (AAA) and most
previous investigations have focused on imaging rather than clinical outcomes. The aim of …

Objective To systematically examine the association between metformin and abdominal
aortic aneurysm (AAA) and provide a basis for the treatment of AAA. Methods Pubmed …

Background Type 2 diabetes mellitus (T2DM) patients have a lower risk of abdominal aortic
aneurysm (AAA) and its comorbidities, which might be associated with the usage of …

Abdominal aortic aneurysm (AAA) may lead to rupture and death if left untreated. While
endovascular or surgical repair is generally recommended for AAA greater than 5–5.5 cm …

Background It has been suggested that diabetes medications, such as metformin, may have
effects that inhibit abdominal aortic aneurysm (AAA) growth. The aim of this study was to …

Background Metformin is a commonly used drug in diabetes mellitus treatment. Recently it
has been suggested that the use of metformin on diabetes mellitus patients may lower the …

Objective Diabetes counteracts formation and rupture of abdominal aortic aneurysms,
possibly through arterial matrix accumulation. Use of metformin, on the other hand, reduces …

Worldwide about 20 million people have an abdominal aortic aneurysm (AAA) and rupture
leads to approximately 200 000 deaths annually. To prevent rupture, early detection and …